KAYLEE DIEKEVERS: Open Payments
NPI 1346938115 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,496 in 61 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $418 · 2025 $1,496
Food & beverage: $1,202Education: $295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $323 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $240 |
| UCB, Inc. | 8 | $210 |
| SANOFI-AVENTIS U.S. LLC | 2 | $195 |
| GENZYME CORPORATION | 7 | $144 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Organon LLC | 11 | $70 |
| Amgen Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, COSENTYX, BLU-U, VTAMA, OTEZLA, EBGLYSS.
Industry payments across MI — which companies pay providers there.
